JESSICA SMITH: Open Payments
NPI 1699081620 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,128 in 101 payments from 24 companies in 2025. Trend: 2023 $1,468 · 2024 $1,956 · 2025 $2,128
Food & beverage: $2,128
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $308 |
| ABBVIE INC. | 18 | $214 |
| Lilly USA, LLC | 12 | $213 |
| Astellas Pharma US Inc | 6 | $201 |
| AstraZeneca Pharmaceuticals LP | 10 | $201 |
| GlaxoSmithKline, LLC. | 8 | $137 |
| Insulet Corporation | 1 | $127 |
| Dexcom, Inc. | 5 | $114 |
| Inspire Medical Systems, Inc. | 1 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $93 |
Products named: Ozempic, Veozah, MOUNJARO, AIRSUPRA, JARDIANCE, OMNIPOD, Dexcom G6 Transmitter, TRELEGY ELLIPTA.
Industry payments across LA — which companies pay providers there.
